Hypertension Drugs Market Size

  • Report ID: 2845
  • Published Date: Sep 08, 2025
  • Report Format: PDF, PPT

Hypertension Drugs Market Outlook:

Hypertension Drugs Market size was valued at USD 27.8 billion in 2025 and is likely to cross USD 39.98 billion by 2035, expanding at more than 3.7% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of hypertension drugs is estimated at USD 28.73 billion.

The market is expanding due to an increase in hypertension cases around the world, as it is a condition caused by chronic kidney infection, apnea, and other factors, and is the most common health disorder among the majority of the global population. As a result, the high demand for hypertension drugs is attributed to the high sales volume of hypertension drugs and their available treatment options.

The growing prevalence of insomnia across the globe is believed to fuel market growth. For instance, insomnia is a common sleep disorder that makes it difficult to fall asleep or sometimes causes a person to wake up early. Insomnia is noticed to be interlinked with hypertension and beta-blockers are highly used to treat insomnia heavily across the globe. For instance, it was stated that in every 3 adults across the globe, one of them has insomnia.


Hypertension Drugs Market size

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of hypertension drugs is estimated at USD 28.73 billion.

The global hypertension drugs market size was around USD 27.8 billion in 2025 and is likely to expand at a CAGR of more than 3.7%, surpassing USD 39.98 billion revenue by 2035.

North America hypertension drugs market is poised to capture 30% share by 2035, driven by the presence of key market players developing innovative hypertension drugs.

Key players in the market include Janssen Global Services, LLC, Atnahs Pharma UK Limited, Sanofi US Services Inc., Pfizer Laboratories Div Pfizer Inc, Merck & Co., Inc., Abbott Laboratories, Daiichi Sankyo Company, Limited, Novartis Pharmaceuticals Corporation, Boehringer Ingelheim group, Lupin Ltd.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos